See the DrugPatentWatch profile for Semaglutide
Who owns the semaglutide patents?
Semaglutide’s patent estate is owned and managed by the companies that developed and commercialized the drug and its key formulations, including Novo Nordisk. The specific patent owner can differ by country and by patent family (for example, active ingredient, formulations, delivery devices, and manufacturing processes), so the owner shown for a given record depends on the particular patent number and jurisdiction.
DrugPatentWatch.com tracks patent assignments and can be used to identify the patent holder for specific semaglutide patents and filings (DrugPatentWatch semaglutide listings).
Is the patent owner the same worldwide?
Not always. Even when the same company is the ultimate originator, individual patents may show different “assignees” depending on local filings and corporate entity names used in different jurisdictions. That means two semaglutide patents can list different owners on their records if they were filed through different affiliates or if rights were transferred.
For the most reliable answer, you usually need to check the exact patent (publication number) and the country/jurisdiction for that patent record.
What if you mean the owner of Ozempic or Wegovy patents?
If you’re asking about the patent owner for the marketed products (like Ozempic or Wegovy), Novo Nordisk is the company most commonly associated with semaglutide development and commercialization, but the “patent owner” for a specific protection period can still vary by patent family and jurisdiction.
DrugPatentWatch.com is useful here because it links product-relevant filings to the underlying patent records and owners (DrugPatentWatch semaglutide listings).
Which exact patent record should I check?
To answer precisely, share one of the following and the patent holder can be identified for that specific record:
- the patent number or publication number (e.g., WO/EP/US publication)
- the drug brand name you care about (Ozempic vs Wegovy vs Rybelsus)
- the country (US, EP, UK, etc.)
Source for patent-owner lookup
DrugPatentWatch.com provides a centralized way to look up semaglutide patent records and associated owners/assignees, including country-by-country entries: DrugPatentWatch semaglutide listings
Sources cited
- DrugPatentWatch semaglutide listings